Minimally invasive treatment of early, good prognosis breast cancer-is this feasible?
- PMID: 38310343
- PMCID: PMC11075978
- DOI: 10.1093/bjr/tqae028
Minimally invasive treatment of early, good prognosis breast cancer-is this feasible?
Abstract
Breast cancer screening programmes frequently detect early, good prognosis breast cancers with significant treatment burden for patients, and associated health-cost implications. Emerging evidence suggests a role for minimally invasive techniques in the management of these patients enabling many women to avoid surgical intervention. Minimally invasive techniques include vacuum-assisted excision, cryoablation, and radiofrequency ablation. We review published evidence in relation to the risks and benefits of each technique and discuss ongoing trials. Data to date are promising, and we predict a trend towards minimally invasive treatment for early, good-prognosis breast cancer as technical skills, suitability criteria, and follow-up protocols are established.
Keywords: breast cancer; breast screening; cryotherapy; minimally invasive surgery; radiofrequency ablation; vacuum-assisted excision.
© The Author(s) 2024. Published by Oxford University Press on behalf of the British Institute of Radiology.
Conflict of interest statement
S.M. reports honoraria from MSD, Roche, BD, Novartis, Lilly, and Astra Zeneca; conference travel and support from Roche, Lilly, and MSD, and institutional research funding from Novartis and Almac Diagnostic Services. S.M. reports grant funding from Cancer Research UK, the National Institute for Health Research (including as Chief Investigator for the SMALL trial) and Breast Cancer Now. The other authors have no conflicts to declare.
Figures



References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical